SS&C TECHNOLOGIES HOLDINGS, INC. financials

  1. Home
  2. Financials
  3. SSNC
SSNC CIK 0001402436

Source: EDGAR filings · Built 2026-06-02T04:06:08Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 1.66B 1.33B 1.16B 1.07B 1.38B 1.15B
EBITDA 2.14B 2.02B 1.88B 1.81B 1.91B 1.71B
Working Capital 376.40M 508.10M 279.60M 233.60M 401.10M 15.20M
Net Debt 7.23B 6.66B 6.54B 6.93B 5.71B 6.62B
Gross Margin 48.17% 48.68% 48.19% 47.61% 47.70% 44.86%
Operating Margin 22.91% 22.84% 21.97% 21.63% 24.60% 21.12%
Net Margin 12.71% 12.93% 11.03% 12.31% 15.84% 13.39%
Return on Equity (ROE) 11.57% 11.64% 9.58% 10.76% 12.98% 10.94%
Return on Assets (ROA) 3.85% 3.99% 3.35% 3.90% 4.62% 3.93%
Current Ratio 1.07× 1.12× 1.07× 1.11× 1.10× 1.01×
Debt-to-Equity 1.12× 1.11× 1.10× 1.22× 1.02× 1.19×
Effective Tax Rate 18.07% 14.77% 29.04% 25.92% 22.80% 19.41%
Cash Conversion Ratio 2.19× 1.83× 2.00× 1.74× 1.79× 1.89×
Accruals Ratio -0.05× -0.03× -0.03× -0.03× -0.04× -0.04×
SBC % of Revenue 4.11% 3.46% 2.90% 2.36% 2.26% 1.88%
CapEx Coverage 21.59× 22.62× 21.47× 17.89× 27.86× 34.04×
Free Cash Flow Per Share $6.57 $5.23 $4.55 $4.09 $5.15 $4.31

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 27.75× 25.26× 25.57× 20.99× 27.42× 30.96×
P/FCF 13.30× 14.49× 13.42× 12.74× 15.91× 16.87×
FCF Yield 7.52% 6.90% 7.45% 7.85% 6.29% 5.93%
EV / EBITDA 13.24× 12.45× 11.50× 11.02× 13.98× 14.82×
P/S 3.36× 3.15× 2.74× 2.47× 4.16× 4.01×
P/B 3.06× 2.84× 2.38× 2.16× 3.40× 3.28×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 6.27B 5.88B 5.50B 5.28B 5.05B 4.67B
Cost of Goods and Services Sold 3.25B 3.02B 2.85B 2.77B 2.64B 2.57B
Gross Profit 3.02B 2.86B 2.65B 2.52B 2.41B 2.09B
Research and Development Expense 507.50M 517.70M 473.80M 447.30M 414.90M 399.40M
Operating Expenses 1.58B 1.52B 1.44B 1.37B 1.17B 1.11B
Operating Income (Loss) 1.44B 1.34B 1.21B 1.14B 1.24B 985.80M
Income Tax Expense (Benefit) 176.10M 132.00M 249.10M 227.10M 236.40M 150.60M
Net Income (Loss) Attributable to Parent 796.90M 760.50M 607.10M 650.20M 800.00M 625.20M
Earnings Per Share, Basic $3.26 $3.09 $2.45 $2.56 $3.13 $2.44
Weighted Average Number of Shares Outstanding, Basic 244.30M 246.40M 248.30M 254.00M 255.60M 256.40M
Earnings Per Share, Diluted $3.15 $3.00 $2.39 $2.48 $2.99 $2.35
Weighted Average Number of Shares Outstanding, Diluted 253.10M 253.80M 254.50M 262.00M 267.30M 266.60M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 462.10M 567.10M 432.20M 440.10M 564.00M 209.30M
Assets, Current 5.49B 4.86B 4.05B 2.42B 4.25B 2.30B
Assets 20.71B 19.04B 18.10B 16.65B 17.33B 15.92B
Liabilities, Current 5.11B 4.35B 3.77B 2.19B 3.85B 2.28B
Long-term Debt, Excluding Current Maturities 7.41B 6.99B 6.67B 7.02B 5.90B 6.39B
Liabilities 13.77B 12.44B 11.70B 10.55B 11.11B 10.21B
Stockholders' Equity Attributable to Parent 6.89B 6.53B 6.34B 6.04B 6.17B 5.72B
Common Stock, Shares, Outstanding 241.40M 244.50M 246.60M 251.00M 256.00M 257.60M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 1.74B 1.39B 1.22B 1.13B 1.43B 1.18B
Payments to Acquire Property, Plant, and Equipment 80.80M 61.40M 56.60M 63.40M 51.30M 34.80M
Net Cash Provided by (Used in) Investing Activities -1.31B -855.70M -268.40M -1.76B -148.20M -210.50M
Payments for Repurchase of Common Stock 1.04B 737.50M 471.60M 476.10M 487.90M 227.70M
Net Cash Provided by (Used in) Financing Activities -243.50M -152.30M 712.80M -1.18B 556.70M -1.43B

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (SSNC CIK 0001402436), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

PALI

PALISADE BIO, INC.

ACTU

ACTUATE THERAPEUTICS, INC.

FITB

Fifth Third Bancorp